Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/CA/Fresno
Updated July 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fresno, CA

Studies commonly pay $75 to $4,500 per completed study

167 clinical trials are currently recruiting participants within 30 miles of Fresno. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

167studies recruiting
4+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Fresno right now

Top 25 of 167 recruiting studies, sorted by proximity — each links to its official registry page

Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis When Used in Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) to Treat Aortoiliac Occlusive Disease

Aortoiliac Occlusive Disease N/A Observational 158 participants sought
University of California — Fresno, California (2.7 mi) · Sponsor: W.L.Gore & Associates
See eligibility & contact on ClinicalTrials.gov (NCT06872905)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Ganglioneuroblastoma, Nodular, Neuroblastoma Phase 3 Interventional 478 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06172296)

A Prospective Multicenter Clinical Investigation Evaluating the Accuracy of the Trimline Design When Treated With SureSmile® Aligners.

Malocclusion N/A Interventional 90 participants sought
Costanzo Orthodontics — Fresno, California (2.7 mi) · Sponsor: Dentsply Sirona Implants and Consumables
See eligibility & contact on ClinicalTrials.gov (NCT07290790)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
Kaiser Permanente Fresno Orchard Plaza — Fresno, California (2.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

International Rare Histiocytic Disorders Registry (IRHDR)

Rare Histiocytic Disorders (RHDs), Erdheim-Chester Disease (ECD) N/A Observational 400 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: The Hospital for Sick Children
See eligibility & contact on ClinicalTrials.gov (NCT02285582)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

Ovarian Carcinoma N/A Interventional 1,956 participants sought
Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04251052)

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma Phase 3 Interventional 62 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT05235165)

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma Phase 2 Interventional 80 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT02981628)

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Breast Carcinoma, Colorectal Carcinoma N/A Observational 2,000 participants sought
Kaiser Permanente Fresno Orchard Plaza — Fresno, California (2.7 mi) · Sponsor: Wake Forest University Health Sciences
See eligibility & contact on ClinicalTrials.gov (NCT06418204)

A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma

B-Cell Non-Hodgkins Lymphoma Phase 2 Interventional 100 participants sought
Community Cancer Institute (CCI) — Clovis, California (5.8 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT06806033)

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia

Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia Phase 3 Interventional 556 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT07022678)

Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.

Hematuria - Cause Not Known N/A Interventional 1,000 participants sought
Urology Associates of Central California — Fresno, California (2.7 mi) · Sponsor: Pacific Edge Limited
See eligibility & contact on ClinicalTrials.gov (NCT06394869)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

Schizophrenia, Schizoaffective Disorder Phase 4 Interventional 50 participants sought
Neurocrine Clinical Site — Fresno, California (2.7 mi) · Sponsor: Neurocrine Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07105111)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought
Fresno Cancer Center — Fresno, California (2.7 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT04852887)

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy

Muscular Atrophy, Spinal Phase 4 Interventional 28 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Hoffmann-La Roche
See eligibility & contact on ClinicalTrials.gov (NCT05861999)

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Intracranial Meningioma, Recurrent Meningioma Phase 2 Interventional 124 participants sought
Kaiser Permanente-Fresno — Fresno, California (2.7 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT02523014)

A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT

Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor Phase 2 Interventional 256 participants sought
Valley Children's Hospital — Madera, California (19.2 mi) · Sponsor: Children's Oncology Group
See eligibility & contact on ClinicalTrials.gov (NCT04322318)

The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease

Sickle Cell Disease Phase 3 Interventional 192 participants sought
University of California San Francisco- Site Number : 8400040 — Fresno, California (2.7 mi) · Sponsor: Sanofi
See eligibility & contact on ClinicalTrials.gov (NCT06975865)

Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot Ulcers

Diabetic Foot Ulcer N/A Interventional 450 participants sought
VA Central California Healthcare — Fresno, California (2.7 mi) · Sponsor: Piomic Medical
See eligibility & contact on ClinicalTrials.gov (NCT05758545)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Kaiser Permanente Fresno Orchard Plaza — Fresno, California (2.7 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)
Google-rated

Top-rated research centers in Fresno

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Fresno Clinical Research Center

★ 5.0
7102 N Fresno St Ste 101, Fresno, CA 93720
(559) 712-6199
"Very kind and very professional"
— Vivian, 5★

Beacon Clinical Resarch Institute

1111 E Warner Ave, Fresno, CA 93720
(410) 718-2908

Valley Research

★ 5.0
550 E Herndon Ave #101, Fresno, CA 93720
(559) 261-0992
"I just completed a diabetic study with Valley Research. I worked with Lucas Anderson and Rowena Liwag. The knowledge that was shared was immense, we…"
— Betty Benoit, 5★

Clinical Research Center

Fresno, CA 93720
(559) 450-7790

Clinical trials in Fresno: what's recruiting

The Fresno area currently has 167 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fresno, the most active research areas are:

  • Cancer & Oncology14 studies
  • Brain & Mental Health1 studies
  • Liver & Kidney1 studies
  • Diabetes & Metabolism1 studies

Every listing shows the study phase, the recruiting site and its distance from Fresno, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fresno

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fresno participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fresno pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fresno?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Fresno safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How often do new paid studies open in Fresno?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fresno.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fresno typically complete one or two studies per year.

Paid clinical trials near Fresno

Other metros within reach

Visalia, CA2 Merced, CA30 Modesto, CA99 Bakersfield, CA70 Salinas, CA44 Stockton, CA100 Santa Maria, CA95 San Jose, CA1,129

More of CA

Long Beach3,341 Torrance3,236 Fullerton3,223 Anaheim3,155 Garden Grove3,152 Pomona3,119 Glendale2,957 Los Angeles2,943 Huntington Beach2,841 Santa Clarita2,395 Hayward2,256 Oakland2,249

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts